Association of cys 311 ser polymorphism of paraoxonase-2 gene with the risk of coronary artery disease.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Archives of Iranian medicine

• Publication date

  2008-09-01

• Fields of study

  Medicine

• Identifiers
  PMID 18759523
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes

  2004cited by this paper
• Interaction between smoking and PON2 Ser311Cys polymorphism as a determinant of the risk of myocardial infarction

  2004cited by this paper
• Association between the severity of angiographic coronary artery disease and paraoxonase gene polymorphisms in the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) study.

  2003cited by this paper
• Species- and substrate-specific stimulation of human plasma paraoxonase 1 (PON1) activity by high chloride concentration.

  2002cited by this paper
• Paraoxonase and coronary heart disease.

  2002cited by this paper
• New strategies in managing and preventing atherosclerosis: focus on HDL.

  2002cited by this paper
• Human Paraoxonase-3 Is an HDL-Associated Enzyme With Biological Activity Similar to Paraoxonase-1 Protein but Is Not Regulated by Oxidized Lipids

  2001cited by this paper
• PON2 gene variants are associated with clinical manifestations of cardiovascular disease in familial hypercholesterolemia patients.

  2001cited by this paper
• Paraoxonase-2 Is a Ubiquitously Expressed Protein with Antioxidant Properties and Is Capable of Preventing Cell-mediated Oxidative Modification of Low Density Lipoprotein*

  2001cited by this paper
• Paraoxonase 192 Gln/Arg gene polymorphism, coronary artery disease, and myocardial infarction in type 2 diabetes.

  1999cited by this paper
• The gln-Arg192 polymorphism of human paraoxonase gene is not associated with coronary artery disease in italian patients.

  1998cited by this paper
• Genetic variation in paraoxonase-1 and paraoxonase-2 is associated with variation in plasma lipoproteins in Alberta Hutterites.

  1998cited by this paper
• Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.

  1998cited by this paper
• DNA polymorphisms in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart disease.

  1998cited by this paper
• Human PON2 gene at 7q21.3: cloning, multiple mRNA forms, and missense polymorphisms in the coding sequence.

  1998cited by this paper
• The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin

  1996cited by this paper
• The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture.

  1996cited by this paper
• The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns.

  1996cited by this paper
• The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family.

  1996cited by this paper
• Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase.

  1993cited by this paper

• Association of Paraoxonase-1 (p.L55M) and Paraoxonase-2 (p.S311C) polymorphisms with coronary artery disease in North Indian Punjabi population

  2025cites this paper
• Paraoxonase 2 C311S single nucleotide polymorphism is associated with type C lesions in coronary atherosclerosis.

  2022cites this paper
• Paraoxonases Activities and Polymorphisms in Elderly and Old-Age Diseases: An Overview

  2019cites this paper
• 16 Electrocardiogram ( ECG ) Abnormality Among Residents in Arseniasis-Endemic and Non-Endemic Areas of Southwestern Taiwan – A Study of Gene-Gene and Gene-Environment Interactions

  2018cites this paper
• PON2 and PPARG polymorphisms as biomarkers of risk for coronary heart disease.

  2018cites this paper
• Genetic Factors of Decreased Kidney Function in Patients with Chronic Glomerulonephritis

  2016cites this paper
• Association Between Paraoxonase 2 Ser311Cys Polymorphism and Coronary Heart Disease Risk: A Meta-Analysis

  2016influential citation
• Clinical and Genetic Research of Chronic Glomerulonephritis

  2016cites this paper
• Paraoxonase 2 Gene (Cys311-Ser) Polymorphism and the Risk of Coronary Artery Disease

  2014influential citation
• Genes involved in the regulation of vascular homeostasis determine renal survival rate in patients with chronic glomerulonephritis.

  2014cites this paper
• Association of Polymorphism of Ser311cys Paraoxonase-2 Gene with Type 2 Diabetes Mellitus in Iran

  2013cites this paper
• Association of PON1 and PON2 Polymorphisms with PON1 Activity and Significant Coronary Stenosis in a Tunisian Population

  2012cites this paper
• The growing importance of PON1 in cardiovascular health: a review.

  2012cites this paper
• Relationship of PON2 gene Ser311Cys polymorphism and serum paraoxonase activity with coronary artery disease in Turkish population

  2012cites this paper
• Electrocardiogram (ECG) Abnormality Among Residents in Arseniasis-Endemic and Non-Endemic Areas of Southwestern Taiwan – A Study of Gene-Gene and Gene-Environment Interactions

  2012cites this paper
• Four genetic polymorphisms of paraoxonase gene and risk of coronary heart disease: a meta-analysis based on 88 case-control studies.

  2011cites this paper
• The Role of Polymorphisms Within Paraoxonases (192 Gln/Arg in PON1 and 311Ser/Cys in PON2) in the Modulation of Cardiovascular Risk: A Pilot Study

  2010cites this paper
• Human paraoxonase 2

  2010cites this paper
• Combining Gene Expression Profiles and Drug Activity Patterns Analysis: A Relational Clustering Approach

  2010cites this paper
• Paraoxonase2 C311S polymorphism and low levels of HDL contribute to a higher mortality risk after acute myocardial infarction in elderly patients.

  2009cites this paper